Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN8A-DEE
CAMBRIDGE, Mass., April 14, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…
Month: April 2021
CohBar to Present at the Mitochondria-Targeted Drug Development Summit
MENLO PARK, Calif., April 14, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical…
CorMedix Has Meeting With FDA on DefenCath Catheter Lock Solution NDA
BERKELEY HEIGHTS, N.J., April 14, 2021 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Agenus Doses First Cancer Patient with iNKT Cell Therapy
LEXINGTON, Mass., April 14, 2021 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company…
I-Mab Announces Selected Poster Presentation of CD73 Antibody Uliledlimab at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
SHANGHAI, China., and GAITHERSBURG, MD, April 14, 2021 (GLOBE NEWSWIRE) — I-Mab (the “Company”) (Nasdaq:…
Homology Medicines Announces Presentations at ACMG Annual Clinical Genetics Meeting
– Data From Company’s PKU and Hunter Syndrome Gene Therapy Programs Featured in Presentations –…
Saniona to Present Preclinical Data on SAN903 at the ASPET Annual Meeting at Experimental Biology 2021
PRESS RELEASE April 14, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on…
BioCryst Announces Approval of Japanese NHI Price Listing of ORLADEYO™ (berotralstat) for Prophylactic Treatment of Hereditary Angioedema
—ORLADEYO is the first and only approved prophylactic therapy for HAE in Japan— —NHI price…
BioSyent to Present at 2021 Bloom Burton & Co. Healthcare Investor Conference
MISSISSAUGA, Ontario, April 14, 2021 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) is…
Aligos Therapeutics Begins Dosing with Capsid Assembly Modulator Drug Candidate, ALG-000184, in First Cohort of Chronic Hepatitis B Patients in a Phase 1 Proof-of-Concept Study
Aligos now evaluating two of its four Chronic Hepatitis B (CHB) portfolio drug candidates in…
Beyond Air® Announces Participation at Upcoming Virtual Investor Conferences in May 2021
GARDEN CITY, N.Y., April 14, 2021 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a…
HOOKIPA Pharma to Present at Kempen Life Science Conference
NEW YORK and VIENNA, Austria, April 14, 2021 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…
Ocugen Inc. Announces John Paul Gabriel as Senior Vice President, Manufacturing and Supply Chain
John Paul (J.P.) Gabriel John Paul (J.P.) Gabriel MALVERN, Pa., April 14, 2021 (GLOBE NEWSWIRE)…
Aruna Bio Closes $10.8 Million Common Stock Financing
Financing will support the advancement of the company’s proprietary neural exosome platform to treat neurodegenerative…
aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
SAN DIEGO, April 14, 2021 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics…
Odyssey Group International Announces Formation of Scientific Advisory Board
Irvine, CA, April 14, 2021 (GLOBE NEWSWIRE) — Odyssey Group International, Inc. (OTCQB:ODYY) (the “Company”…
Lowell Farms and Ascend Wellness Holdings Announce Strategic Licensing Agreement, Bringing Award-Winning Lowell Smokes to Illinois and Massachusetts
Lowell Smokes award-winning pre-rolls available this summer in two of the top four largest cannabis…
Humacyte Secures $50 Million Debt Facility with Silicon Valley Bank
DURHAM, N.C., April 14, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc., a clinical-stage biotechnology platform company…
Inozyme Pharma Presents Data from Burden of Illness Study in Patients with ENPP1 Deficiency and ABCC6 Deficiency at the 2021 Annual Clinical Genetics Meeting of the American College of Medical Genetics and Genomics
– Study results underscore high and shifting disease impacts across age groups, reflecting evolution of…
Theratechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights
MONTREAL, April 14, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ:…